2021 Digital International Liver Conference*

Hear insights from Stefan Zeuzem, MD, on exciting new data on viral hepatitis reported at the virtual EASL 2021, including new findings on treatment of HDV, treatment of HBV and HCV in children, linking patients to care, and new molecules being investigated for HBV cure.

Stefan Zeuzem, MD Released: July 19, 2021

Hear a rapid update of the top HBV, HCV, and HDV studies from the Virtual 2021 International Liver Congress, 2021.

Tarik Asselah, MD, PhD Released: July 20, 2021

Hear a rapid update of the top HBV, HCV, and HDV studies from the Virtual 2021 International Liver Congress, 2021.

Stefan Zeuzem, MD Released: July 22, 2021

In this downloadable slideset, CCO’s expert faculty members summarize key viral hepatitis studies from this important conference, including new data on treatment of HDV, treatment of HBV and HCV in children, linking patients to care, and new molecules being investigated for HBV cure.

Tarik Asselah, MD, PhD Robert G. Gish, MD Nancy Reau, MD Stefan Zeuzem, MD Released: July 15, 2021

Now that the horizon is getting closer, our job now is to identify our HDV-infected patients and prepare them for treatment.

Nancy Reau, MD Released: July 22, 2021

My thoughts on which HBV cure strategies might be fruitful.

Robert G. Gish, MD Released: July 22, 2021